Relay Therapeutics, Inc. (RLAY) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$276.48M | +18.1% |
| 2024 | -$337.71M | +1.2% |
| 2023 | -$341.97M | -17.7% |
| 2022 | -$290.51M | +20.2% |
| 2021 | -$363.87M | -594.3% |
| 2020 | -$52.41M | +30.4% |
| 2019 | -$75.31M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$276.48M | +18.1% |
| 2024 | -$337.71M | +1.2% |
| 2023 | -$341.97M | -17.7% |
| 2022 | -$290.51M | +20.2% |
| 2021 | -$363.87M | -594.3% |
| 2020 | -$52.41M | +30.4% |
| 2019 | -$75.31M | — |